naltrexone has been researched along with alfentanil in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (57.14) | 18.2507 |
2000's | 5 (35.71) | 29.6817 |
2010's | 1 (7.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jolivette, LJ; Ward, KW | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
France, CP; Medzihradsky, F; Rice, KC; Seggel, MR; Winger, G; Woods, JH | 1 |
Butelman, ER; DeCosta, BR; Walker, EA; Woods, JH | 1 |
France, CP; Gerak, LR | 1 |
Kitchen, I; Muhammad, BY | 1 |
Koob, GF; Negus, SS; Pasternak, GW; Weinger, MB | 1 |
Antelo, MT; Fernández, B; Kitchen, I; Viveros, MP | 2 |
Chang, KJ; McNutt, RW; Su, YF | 1 |
Cox, E; Danhof, M; Garrido, M; Gubbens-Stibbe, J; IJzerman, A; Künzel, D; Tukker, E; van der Graaf, PH; von Frijtag, J | 1 |
Fantegrossi, WE; Galuska, CM; Ko, MC; Prinssen, EP; Wichmann, J; Woods, JH | 1 |
1 review(s) available for naltrexone and alfentanil
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
13 other study(ies) available for naltrexone and alfentanil
Article | Year |
---|---|
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Mirfentanil: pharmacological profile of a novel fentanyl derivative with opioid and nonopioid effects.
Topics: Alfentanil; Analgesics; Animals; Columbidae; Discrimination Learning; Female; Fentanyl; In Vitro Techniques; Macaca mulatta; Male; Morphine; Naltrexone; Receptors, Opioid; Receptors, Opioid, mu; Respiration; Self Administration; Structure-Activity Relationship | 1991 |
Opioid thermal antinociception in rhesus monkeys: receptor mechanisms and temperature dependency.
Topics: Alfentanil; Analgesics; Animals; Azocines; Benzimidazoles; Benzomorphans; Dose-Response Relationship, Drug; Female; Hot Temperature; Macaca mulatta; Male; Nalbuphine; Naltrexone; Nociceptors; Pyrrolidines; Receptors, Opioid; Tail | 1993 |
Behavioral effects of 6-methylene naltrexone (nalmefene) in rhesus monkeys.
Topics: Alfentanil; Analgesics; Animals; Behavior, Animal; Benzofurans; Female; Macaca mulatta; Male; Molecular Structure; Nalbuphine; Naltrexone; Narcotic Antagonists; Pyrrolidines | 1994 |
Effect of delayed weaning on opioid receptor control of swim stress-induced antinociception in the developing rat.
Topics: Alfentanil; Analgesia; Animals; Female; Male; Naloxone; Naltrexone; Narcotic Antagonists; Pain Measurement; Rats; Rats, Wistar; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, mu; Stress, Psychological; Swimming; Weaning | 1993 |
Antagonist effects of beta-funaltrexamine and naloxonazine on alfentanil-induced antinociception and muscle rigidity in the rat.
Topics: Alfentanil; Analgesia; Animals; Electromyography; Male; Muscle Rigidity; Naloxone; Naltrexone; Narcotic Antagonists; Rats; Rats, Wistar | 1993 |
Effects of preweanling chronic naltrindole administration on stress-induced antinociceptive responses in rats.
Topics: Aging; Alfentanil; Analgesics, Opioid; Animals; Animals, Newborn; Drug Administration Schedule; Female; Naltrexone; Narcotic Antagonists; Pain; Rats; Rats, Wistar; Receptors, Opioid, delta; Receptors, Opioid, mu; Stress, Psychological; Swimming | 1998 |
Delta-opioid ligands reverse alfentanil-induced respiratory depression but not antinociception.
Topics: Alfentanil; Analgesics, Opioid; Animals; Benzamides; Hypercapnia; Ligands; Male; Naltrexone; Narcotic Antagonists; Narcotics; Oligopeptides; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, mu; Respiration; Respiratory Insufficiency; Somatostatin | 1998 |
Effects of neonatal naltrindole treatment on antinociceptive and behavioral responses to mu and kappa agonists in rats.
Topics: Alfentanil; Animals; Animals, Newborn; Benzofurans; Male; Naltrexone; Narcotic Antagonists; Narcotics; Pain Measurement; Psychomotor Performance; Pyrrolidines; Rats; Rats, Wistar; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu | 1999 |
Pharmacokinetic-pharmacodynamic analysis of the EEG effect of alfentanil in rats following beta-funaltrexamine-induced mu-opioid receptor "knockdown" in vivo.
Topics: Alfentanil; Analgesics, Opioid; Animals; Electroencephalography; Male; Naltrexone; Narcotic Antagonists; Radioligand Assay; Rats; Rats, Wistar; Receptors, Opioid, mu | 2000 |
Behavioral effects of a synthetic agonist selective for nociceptin/orphanin FQ peptide receptors in monkeys.
Topics: Alfentanil; Analgesics, Opioid; Animals; Behavior, Animal; Benzimidazoles; Capsaicin; Central Nervous System Agents; Dose-Response Relationship, Drug; Female; Hot Temperature; Imidazoles; Macaca mulatta; Male; Naltrexone; Narcotic Antagonists; Nociceptin Receptor; Pain; Piperidines; Pruritus; Receptors, Opioid; Receptors, Opioid, mu; Reinforcement, Psychology; Respiratory Insufficiency; Spiro Compounds | 2009 |